Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Grand Challenges Canada | OTHER |
| National Tuberculosis Control Center, Ministry of Health, Republic of Armenia | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Randomized trial tests effectiveness of self-administered drug intake by empowered TB patients - supervised by a trained family member and supported by medical counseling and reminders - to improve treatment adherence and treatment success rates, and thereby forestall TB and MDR-TB epidemics.
The innovative treatment approach integrates several educational, technological, and social evidence-based components. The aim of this study is to pilot the innovative approach for drug-sensitive TB patients during the outpatient phase of tuberculosis treatment. To test the effectiveness of the innovative approach (intervention) a randomized controlled trial with two arms will be conducted. The intervention arm will include drug-sensitive tuberculosis patients that are treated according to the innovative approach, which includes self-administered drug intake supervised by a family member, TB patient and family member training (including distribution of a leaflet about TB) and psychological counseling, reminder text messages to TB patients, and reminder phone call to TB patient family members. The control arm will include drug-sensitive tuberculosis patients that receive the regular Directly Observed Therapy recommended by the World Health Organization.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention arm | Experimental | The intervention includes the following components: self-administered drug intake strategy, TB knowledge and socio-psychological counseling session, SMS text messages, phone calls, educational leaflet |
|
| Control arm | No Intervention | patients included in the control arm will receive traditional - clinical Directly Observed Therapy (DOT) as recommended by WHO |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TB knowledge and socio-psychological counseling session | Behavioral | TB patients and their family members will participate in one-day counseling session provided by a trained psychologist and a TB nurse |
| Measure | Description | Time Frame |
|---|---|---|
| TB Treatment Success Rates Defined by the World Health Organization (WHO) | The sum of cured (TB patients with bacteriologically confirmed TB at the beginning of treatment who were smear- or culture-negative in the last month of treatment and on at least one previous occasion) and treatment completed (TB patients who completed treatment without evidence of failure but with no record to show that sputum smear or culture results in the last month of treatment and on at least one previous occasion were negative,either because tests were not done or because results are unavailable). | Patients were followed for the duration of ambulatory phase of treatment, an average of 4.2 months |
| Measure | Description | Time Frame |
|---|---|---|
| Knowledge About TB Infection | Knowledge about TB infection will be measured by surveys | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) |
| Stigma Level Towards TB Patients |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Varduhi Petrosyan, MS, PHD | American University of Armenia Fund | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| School of Public Health, American University of Armenia Fund | Yerevan | 0019 | Armenia |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 16546538 | Background | Newell JN, Baral SC, Pande SB, Bam DS, Malla P. Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet. 2006 Mar 18;367(9514):903-9. doi: 10.1016/S0140-6736(06)68380-3. | |
| Background | Raza S, Sarfaraz M, Ahmad M. Practice of family and non-family based directly observed treatment for tuberculosis in Pakistan: A retrospective cohort study. The Health 2012; 3(2): 39-44 | ||
| 11687192 |
Not provided
Not provided
Not provided
Between 12 March and 26 December 2014, we identified and contacted eligible TB patients from the intervention TB out-patient clinics as well as the control TB out-patient clinics.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Intervention Arm | The intervention included the following components: self-administered drug intake strategy, TB knowledge and socio-psychological counseling session, SMS text messages, phone calls, educational leaflet. |
| FG001 | Control Arm | Patients included in the control arm received traditional - clinical Directly Observed Therapy (DOT) as recommended by WHO. |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Intervention Arm | The intervention included the following components: self-administered drug intake strategy, TB knowledge and socio-psychological counseling session, SMS text messages, phone calls, educational leaflet. |
| BG001 | Control Arm |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | TB Treatment Success Rates Defined by the World Health Organization (WHO) | The sum of cured (TB patients with bacteriologically confirmed TB at the beginning of treatment who were smear- or culture-negative in the last month of treatment and on at least one previous occasion) and treatment completed (TB patients who completed treatment without evidence of failure but with no record to show that sputum smear or culture results in the last month of treatment and on at least one previous occasion were negative,either because tests were not done or because results are unavailable). | Posted | Count of Participants | Participants | Patients were followed for the duration of ambulatory phase of treatment, an average of 4.2 months |
|
Throughout the study period (average 4.2 months)
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Intervention Arm | The intervention includes the following components: self-administered drug intake strategy, TB knowledge and socio-psychological counseling session, SMS text messages, phone calls, educational leaflet. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Death | Respiratory, thoracic and mediastinal disorders | Non-systematic Assessment |
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Harutyunyan | American University of Armenia | aharutyunyan@aua.am |
Not provided
| ID | Term |
|---|---|
| D014376 | Tuberculosis |
| D023801 | Directly Observed Therapy |
| ID | Term |
|---|---|
| D009164 | Mycobacterium Infections |
| D000193 | Actinomycetales Infections |
| D016908 | Gram-Positive Bacterial Infections |
| D001424 | Bacterial Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| SMS text messages | Other | TB patients will receive SMS text messages every morning (except Sunday) during the whole ambulatory TB treatment phase as a reminder for taking the TB medication prescribed and provided by the TB physician |
|
| phone calls | Other | Family members of the TB patients will receive phone calls every evening (except Sunday) during the whole ambulatory TB treatment phase to assure that the patient takes the medication prescribed and provided by the TB physician and to collect information on treatment adherence and possible side effects. |
|
| Self-administered drug intake strategy | Behavioral | Once a week TB patients will receive the TB medication from their local outpatient TB centers and will use the medication every day (six days a week, except Sunday according to the TB treatment protocol) at home under supervision of a family member in charge. |
|
| Educational leaflet | Behavioral | Educational leaflet containing information on TB infection; infection control measures; importance of TB treatment adherence and family support will be provided to all TB patients at the end of the counselling session |
|
Stigma level towards TB patients will be measured by surveys |
| At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) |
| Family Support Towards TB Patients | Change in family support towards TB patients will be measured by surveys | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) |
| TB Treatment Adherence | TB treatment adherence will be measured by surveys | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) |
| Depression Status of TB Patients | Depression status of TB patients will be measured by surveys | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) |
| Quality of Life of TB Patients | Quality of life of TB patients will be measured by surveys | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) |
| Background |
| Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2001;(4):CD003343. doi: 10.1002/14651858.CD003343. |
| Background | Truzyan N, Harutyunyan T, Koshkakaryan M, Petrosyan V. Household TB Infection Control Pilot Project: Counseling for TB Patients and Their Family Members. American University of Armenia School of Public Health, Center for Health Services Research and Development, Yerevan, Armenia, 2013 |
| 32334553 | Derived | Khachadourian V, Truzyan N, Harutyunyan A, Petrosyan V, Davtyan H, Davtyan K, van den Boom M, Thompson ME. People-centred care versus clinic-based DOT for continuation phase TB treatment in Armenia: a cluster randomized trial. BMC Pulm Med. 2020 Apr 25;20(1):105. doi: 10.1186/s12890-020-1141-y. |
| 26093675 | Derived | Khachadourian V, Truzyan N, Harutyunyan A, Thompson ME, Harutyunyan T, Petrosyan V. People-centered tuberculosis care versus standard directly observed therapy: study protocol for a cluster randomized controlled trial. Trials. 2015 Jun 22;16:281. doi: 10.1186/s13063-015-0802-2. |
Patients included in the control arm received traditional - clinical Directly Observed Therapy (DOT) as recommended by WHO. |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| OG001 | Intervention Arm | The intervention includes the following components: self-administered drug intake strategy, TB knowledge and socio-psychological counseling session, SMS text messages, phone calls, educational leaflet |
|
|
| Secondary | Knowledge About TB Infection | Knowledge about TB infection will be measured by surveys | Not Posted | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) | Participants |
| Secondary | Stigma Level Towards TB Patients | Stigma level towards TB patients will be measured by surveys | Not Posted | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) | Participants |
| Secondary | Family Support Towards TB Patients | Change in family support towards TB patients will be measured by surveys | Not Posted | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) | Participants |
| Secondary | TB Treatment Adherence | TB treatment adherence will be measured by surveys | Not Posted | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) | Participants |
| Secondary | Depression Status of TB Patients | Depression status of TB patients will be measured by surveys | Not Posted | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) | Participants |
| Secondary | Quality of Life of TB Patients | Quality of life of TB patients will be measured by surveys | Not Posted | At baseline and upon completion of the treatment (an expected average of 4.5 months after starting the ambulatory phase of the treatment) | Participants |
| 3 |
| 194 |
| 0 |
| 194 |
| EG001 | Control Arm | Patients included in the control arm received traditional - clinical Directly Observed Therapy (DOT) as recommended by WHO. | 3 | 198 | 0 | 198 |
| Death | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Non-systematic Assessment |
|
Not provided
Not provided
Not provided
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
| D055118 | Medication Adherence |
| D010349 | Patient Compliance |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |